NO20023640L - Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner - Google Patents

Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner

Info

Publication number
NO20023640L
NO20023640L NO20023640A NO20023640A NO20023640L NO 20023640 L NO20023640 L NO 20023640L NO 20023640 A NO20023640 A NO 20023640A NO 20023640 A NO20023640 A NO 20023640A NO 20023640 L NO20023640 L NO 20023640L
Authority
NO
Norway
Prior art keywords
mucins
synthesis
maintaining
improving
disease states
Prior art date
Application number
NO20023640A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023640D0 (no
Inventor
Olivier Ballevre
Paul-Andre Finot
Denis Breuille
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27052980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20023640(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/774,814 external-priority patent/US6833350B2/en
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO20023640D0 publication Critical patent/NO20023640D0/no
Publication of NO20023640L publication Critical patent/NO20023640L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20023640A 2000-02-04 2002-07-31 Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner NO20023640L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49890500A 2000-02-04 2000-02-04
US09/774,814 US6833350B2 (en) 2000-02-04 2001-01-30 Method for maintaining or improving the synthesis of mucins
PCT/EP2001/001013 WO2001056405A2 (en) 2000-02-04 2001-01-31 A method for maintaining or improving the synthesis of mucins

Publications (2)

Publication Number Publication Date
NO20023640D0 NO20023640D0 (no) 2002-07-31
NO20023640L true NO20023640L (no) 2002-09-19

Family

ID=27052980

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023640A NO20023640L (no) 2000-02-04 2002-07-31 Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner

Country Status (22)

Country Link
EP (1) EP1255452B2 (hu)
JP (1) JP2003533436A (hu)
CN (1) CN1434681B (hu)
AT (1) ATE323422T1 (hu)
AU (1) AU784137B2 (hu)
BG (1) BG106967A (hu)
BR (1) BRPI0108096B1 (hu)
CA (1) CA2399063C (hu)
CZ (1) CZ20022978A3 (hu)
DE (1) DE60118888T3 (hu)
DZ (1) DZ3298A1 (hu)
ES (1) ES2261383T5 (hu)
HR (1) HRP20020647A2 (hu)
HU (1) HUP0204439A3 (hu)
IL (1) IL150977A (hu)
MA (1) MA25656A1 (hu)
MX (1) MXPA02007491A (hu)
NO (1) NO20023640L (hu)
NZ (1) NZ520605A (hu)
PL (1) PL357078A1 (hu)
SK (1) SK11212002A3 (hu)
WO (1) WO2001056405A2 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070036836A1 (en) 2003-06-23 2007-02-15 Magali Faure Amino acid supplementation for a healthy microbiota ecosystem
JPWO2007004613A1 (ja) * 2005-07-01 2009-01-29 味の素株式会社 炎症性腸疾患治療薬及びＴＮＦ−α産生抑制剤
JP2009522334A (ja) * 2006-01-09 2009-06-11 ネステク ソシエテ アノニム ストレス下にある患者の処置
WO2012133198A1 (ja) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
MY182335A (en) 2011-07-22 2021-01-19 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP3167895A1 (en) * 2015-11-10 2017-05-17 University College Dublin A dietary supplement comprising beta-glucan and casein hydrolysate for improving health and growth performance in a mammal

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
JP2805490B2 (ja) * 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
JP3007694B2 (ja) * 1990-12-14 2000-02-07 雪印乳業株式会社 胃潰瘍予防または治療のための医薬及び飲食品
ES2173109T3 (es) * 1992-12-23 2002-10-16 Abbott Lab Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas.
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
JPH07267855A (ja) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk グルタミン産生剤
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5670157A (en) * 1995-12-11 1997-09-23 Nestec Ltd. Method for reducing and controlling immunoglobulin concentrations
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
ATE329500T1 (de) * 1997-09-16 2006-07-15 Nestle Sa Verwendung eines organspezifischen ernährungmittels
CA2331921A1 (en) * 1998-06-24 1999-12-29 Boyce Thompson Institute For Plant Research, Inc. A novel invertebrate intestinal mucin cdna and related products and methods
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
NZ518319A (en) * 1999-10-22 2004-04-30 Univ Nebraska Nucleic acid molecules encoding serum amyloid A isoforms from mammalian colostrum used to treat and prevent enteric infections

Also Published As

Publication number Publication date
ES2261383T3 (es) 2010-06-14
WO2001056405A2 (en) 2001-08-09
CN1434681B (zh) 2010-12-08
BRPI0108096B1 (pt) 2017-05-09
DE60118888T2 (de) 2007-01-18
NZ520605A (en) 2004-06-25
CA2399063A1 (en) 2001-08-09
MA25656A1 (fr) 2002-12-31
BG106967A (bg) 2003-04-30
SK11212002A3 (sk) 2003-01-09
CN1434681A (zh) 2003-08-06
EP1255452B1 (en) 2006-04-19
HUP0204439A3 (en) 2004-12-28
JP2003533436A (ja) 2003-11-11
DE60118888D1 (de) 2006-05-24
NO20023640D0 (no) 2002-07-31
CA2399063C (en) 2014-01-28
WO2001056405A3 (en) 2002-01-24
AU784137B2 (en) 2006-02-09
EP1255452A2 (en) 2002-11-13
PL357078A1 (en) 2004-07-12
IL150977A (en) 2005-09-25
DZ3298A1 (fr) 2001-08-09
HRP20020647A2 (en) 2004-12-31
ATE323422T1 (de) 2006-05-15
AU4056401A (en) 2001-08-14
IL150977A0 (en) 2003-02-12
CZ20022978A3 (cs) 2003-02-12
ES2261383T5 (es) 2010-06-18
EP1255452B2 (en) 2010-03-03
MXPA02007491A (es) 2002-12-13
BR0108096A (pt) 2002-10-29
DE60118888T3 (de) 2010-09-23
HUP0204439A2 (hu) 2003-04-28

Similar Documents

Publication Publication Date Title
TW200503708A (en) Gyrase inhibitors and uses thereof
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
WO2003077828A3 (en) Novel florfenicol-type antibiotics
MY141972A (en) Biaryloxymethylarenecarboxylic acids
MY138708A (en) Biaryloxymethylarenecarboxylic acids
HUP0100566A2 (hu) Új eritromicinszármazékok
HUP0301819A2 (hu) Illóolajok alkalmazása Helicobacter-szerű organizmusok által előidézett gyomor- és bélrendszeri fertőzések leküzdésére
MXPA03011546A (es) Formulacion farmaceutica.
WO2007057873A3 (en) Novel compositions to improve gut health and animal performance and methods of making the same
ME00106B (me) Derivati aminoalkenilbenzoil-benzofurana ili benzotiopena, postupak za njihovo pripremanje i kompozicije koje ih sadrže
BRPI0414868A (pt) composições e métodos compreendendo compostos relacionados com prostaglandina e peptìdios da famìlia do fator trifoliado para o tratamento de glaucoma com hiperemia reduzida
WO2005037839A8 (fr) Composes derives de norcantharidine, leurs procedes de preparation, les compositions les contenant et leurs utilisations.
EA200300066A1 (ru) Производные аминоалкоксибензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции
NO20023640D0 (no) Fremgangsmåte for opprettholdelse av eller forbedring av syntese av muciner
EP1594509A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF IRRITABLE COLON SYNDROME AND NON ULCEREUS DYSPEPSIS
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
YU58102A (sh) Postupak za održavanje ili poboljšanje sinteze mucina
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
DE60213802D1 (de) Cak inhibitoren und deren verwendungen
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
WO2009089147A3 (en) Methods and compositions for the treatment of cancers and pathogenic infections
DE60104866D1 (de) Aminoalkenylbenzoyl-benzofurane oder benzothiophene, verfahren zur ihrer herstellung und sie enthaltende zubereitungen
WO2022056369A3 (en) Small molecule inhibitors of bacterial toxins
BRPI0511945A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
MXPA05006296A (es) Uso de tiazolobenzoheterociclos para el tratamiento de la esclerosis multiple.